Reviewing Data on Lenvatinib plus Pembrolizumab Combination Treatment for Advanced Renal Cell Carcinoma - Episode 5

A Role for Single Agent TKI Therapies in Treating Renal Cell Carcinoma

,

Oncologists debate whether TKI monotherapy has a place in renal cell carcinoma treatment after the CLEAR trial.